152 related articles for article (PubMed ID: 10886102)
21. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
[TBL] [Abstract][Full Text] [Related]
22. The genetic basis of cancer of the kidney.
Linehan WM; Walther MM; Zbar B
J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372
[TBL] [Abstract][Full Text] [Related]
23. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
24. Genetic and clinical aspects of familial renal neoplasms.
Iliopoulos O; Eng C
Semin Oncol; 2000 Apr; 27(2):138-49. PubMed ID: 10768593
[TBL] [Abstract][Full Text] [Related]
25. [Prevention of renal carcinoma: the nutri-genetic approach].
Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
[TBL] [Abstract][Full Text] [Related]
26. [Molecular genetic mechanism of the kidney cancer].
Nakaigawa N; Yao M; Kishida T; Kubota Y
Nihon Rinsho; 2001 Jan; 59(1):104-9. PubMed ID: 11197838
[TBL] [Abstract][Full Text] [Related]
27. The challenge of kidney lesions in von Hippel-Lindau disease.
Neumann HP; Riegler P; Huber W; Corradini R; Sessa A; Fontana D; Wetterauer U; Janetschek G
Contrib Nephrol; 2001; (136):193-207. PubMed ID: 11688380
[No Abstract] [Full Text] [Related]
28. Clinical and molecular diagnosis in inherited kidney diseases: three examples.
Grünfeld JP; Lesavre P; Richard S
Contrib Nephrol; 1997; 122():124-8. PubMed ID: 9399053
[No Abstract] [Full Text] [Related]
29. [VHL gene and TSC 2 gene].
Hino O
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1386-91. PubMed ID: 9309130
[TBL] [Abstract][Full Text] [Related]
30. Pheochromocytoma and clear-cell renal carcinoma in a child with von Hippel-Lindau disease: a patient report.
Ferragut J; Caimari M; Rituerto B; Gómez-Rivas B; Herrera M; Alonso F
J Pediatr Endocrinol Metab; 1999; 12(4):579-82. PubMed ID: 10417977
[TBL] [Abstract][Full Text] [Related]
31. Treatment of renal-cell cancer by transplantation of allogeneic stem cells.
Burk RD
N Engl J Med; 2001 Jan; 344(2):137; author reply 138. PubMed ID: 11188410
[No Abstract] [Full Text] [Related]
32. Genetic disorders and renal cell carcinoma.
Maranchie JK; Linehan WM
Urol Clin North Am; 2003 Feb; 30(1):133-41. PubMed ID: 12580565
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.
Wykoff CC; Pugh CW; Maxwell PH; Harris AL; Ratcliffe PJ
Oncogene; 2000 Dec; 19(54):6297-305. PubMed ID: 11175344
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
[TBL] [Abstract][Full Text] [Related]
35. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.
Petrella BL; Lohi J; Brinckerhoff CE
Oncogene; 2005 Feb; 24(6):1043-52. PubMed ID: 15592504
[TBL] [Abstract][Full Text] [Related]
36. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
Kaelin WG
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
[TBL] [Abstract][Full Text] [Related]
37. von Hippel-Lindau disease.
Couch V; Lindor NM; Karnes PS; Michels VV
Mayo Clin Proc; 2000 Mar; 75(3):265-72. PubMed ID: 10725953
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the urokinase-type plasminogen activator system by the von Hippel-Lindau tumor suppressor gene.
Los M; Zeamari S; Foekens JA; Gebbink MF; Voest EE
Cancer Res; 1999 Sep; 59(17):4440-5. PubMed ID: 10485495
[TBL] [Abstract][Full Text] [Related]
39. Genotype-phenotype correlation in von Hippel-Lindau syndrome.
Friedrich CA
Hum Mol Genet; 2001 Apr; 10(7):763-7. PubMed ID: 11257110
[TBL] [Abstract][Full Text] [Related]
40. VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma.
Schraml P; Struckmann K; Hatz F; Sonnet S; Kully C; Gasser T; Sauter G; Mihatsch MJ; Moch H
J Pathol; 2002 Feb; 196(2):186-93. PubMed ID: 11793370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
